Nuclear Medicine & Molecular Imaging Clinical Trials

• Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer

  The study will be conducted as an open label, single-dose, explorative study with patientswith histologically proven cancer and, preferably, tumor positive lesions in previouslyperformed nuclear medicine imaging examinations.
  
  The investigational drug will be given as a single administration in a dose of

  Investigators

  • Sanjiv Sam Gambhir, MD, PhD
  • Frederick T. Chin, Ph.D.
  • Andrei Iagaru
  Not accepting patients at this time View Details

• Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

  This phase II trial is studying the side effects of and how well alisertib works in treatingyoung patients with relapsed or refractory solid tumors or leukemia. Alisertib may stop thegrowth of cancer cells by blocking some of the enzymes needed for cell growth.

  Investigator

  • Neyssa Marina
  Not accepting patients at this time View Details